Links

Tools

Export citation

Search in Google Scholar

Lowest acquisition drug cost directly acting antiviral (DAA) treatment for hepatitis C (HCV): high cure rates in a difficult to treat HIV/HCV population

This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown